title: Anti-lipid trial endpoints.
authors.affiliation: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20857, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Orloff
mesh_terms: D000367:Age Factors; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors